US5674513A — Anti-bacterial/anti-viral coatings, coating proce…

Claim 1

Independent Claim 303 words

A method of imparting anti-pathogenic properties to a substrate material wherein said method includes preparation of an anti-pathogenic coating solution and subsequently using said coating solution to coat said substrate, said method comprising: (a) preparing a coating composition containing an anti-pathogenic agent consisting essentially of PVP-I and N-9 in a ratio of from about 100:0 to about ):100 of PVP-I to N-9, the coating composition further containing a premix solution with which the anti-pathogenic agent is intimately mixed in a ratio of from about 6:4 to about 8:2 of agent to pre-mix on a dry basis, and having a percent solids content of from about 5% to about 35% solids, said coating composition being prepared by (i) preparing a solution of polyethylene glycol (PEG) in a mixture of alcohol and water; (ii) adding a surfactant comprising a polyethylene glycol sorbitan fatty acid ester compound and an alcohol/water solution to the PEG solution with stirring until homogeneously mixed; (iii) adding to the mixture of step (ii) a prepared powder mixture comprising hydroxypropyl methylcellulose and hydrous magnesium silicate and stirring to obtain a homogeneous solution of the power mixture of step (ii); (iv) stirring the solution of step (iii) for a time sufficient to affect a homogeneous mixture thereof; and (v) adding with stirring to the homogeneous solution of step (iv) a pre-prepared solution comprising a mixture of (1) a solution of PVP-I in an ethanol/water solvent and (2) a solution of N-9 in an ethanol/water solvent, the resulting anti-pathogenic composition exhibiting a viscosity of about 50-600 cps; (b) feeding the anti-pathogenic coating composition into a coating machine; (c) loading a substrate onto the coating machine; (d) operating the coating machine such that the coating composition comes into intimate contact with at least one surface of the substrate; and (e) drying the coated substrate material.

Claim 2

Independent Claim 303 words

A method of imparting anti-pathogenic properties to a substrate material wherein said method includes preparation of an anti-pathogenic coating solution and subsequently using said coating solution to coat said substrate, said method comprising: (a) preparing a coating composition containing an anti-pathogenic agent consisting essentially of PVP-I and N-9 in a ratio of from about 100:0 to about ):100 of PVP-I to N-9, the coating composition further containing a premix solution with which the anti-pathogenic agent is intimately mixed in a ratio of from about 6:4 to about 8:2 of agent to pre-mix on a dry basis, and having a percent solids content of from about 5% to about 35% solids, said coating composition being prepared by (i) preparing a solution of polyethylene glycol (PEG) in a mixture of alcohol and water; (ii) adding a surfactant comprising a polyethylene glycol sorbitan fatty acid ester compound and an alcohol/water solution to the PEG solution with stirring until homogeneously mixed; (iii) adding to the mixture of step (ii) a prepared powder mixture comprising hydroxypropyl methylcellulose and hydrous magnesium silicate and stirring to obtain a homogeneous solution of the power mixture of step (ii); (iv) stirring the solution of step (iii) for a time sufficient to affect a homogeneous mixture thereof; and (v) adding with stirring to the homogeneous solution of step (iv) a pre-prepared solution comprising a mixture of (1) a solution of PVP-I in an ethanol/water solvent and (2) a solution of N-9 in an ethanol/water solvent, the resulting anti-pathogenic composition exhibiting a viscosity of about 50-600 cps; (b) feeding the anti-pathogenic coating composition into a coating machine; (c) loading a substrate onto the coating machine; (d) operating the coating machine such that the coating composition comes into intimate contact with at least one surface of the substrate; and (e) drying the coated substrate material.

Claim 3

Dependent Claim 15 words

The method of claim 1 wherein the coating machine is a reverse roll coating machine.

Claim 4

Dependent Claim 43 words

The method of claim 1 wherein the substrate is a paper substrate of between about 10 lb./3000 ft 2 and about 30 lb./3000 ft 2 , and the coating composition used has a percent solids content of between about 20% and about 35%.

Claim 5

Dependent Claim 25 words

The method of claim 2 wherein the substrate is a laminate material and the coating composition used has a percent solids content of about 20%.

Claim 6

Dependent Claim 16 words

The method of claim 4 wherein the substrate is a paper laminated to a polymeric film.

Claim 7

Dependent Claim 12 words

The method of claim 2 wherein the substrate is a non-woven material.

Claim 8

Dependent Claim 14 words

The method of claim 1 wherein the coating machine is a rod coating machine.

Claim 9

Dependent Claim 29 words

The method of claim 7 wherein the substrate is a laminate material and the coating composition used has a percent solids content of between about 30% and about 33%.

Claim 10

Dependent Claim 12 words

The method of claim 7 wherein the substrate is a non-woven material.

Claim 11

Dependent Claim 36 words

The method of claim 1 wherein the coating machine is a spray coater and coating composition, which has a percent solids content of between about 5% and about 20%, is atomized prior to contacting the substrate.

Claim 12

Dependent Claim 29 words

The method of claim 10 wherein the substrate is selected from the group consisting of paper, non-woven material, coated paper and laminates of paper, non-woven material and polymeric film.

Claim 13

Dependent Claim 30 words

The method of claim 1 wherein the coating machine is a dip coating machine and the coating composition used has a percent solids of between about 5% and about 20%.

Claim 14

Dependent Claim 110 words

A process for producing a substrate coated with a formulation containing an anti-pathogenic component comprising: (a) depositing onto at least one surface of a substrate material a coating formulation in solution, characterized by the inclusion of PVP-I and N-9 as the active anti-pathogenic agent in a ratio of from about 100:0 to about 0:100 respectively and further including a premix solution in a ratio of about 6:4 to about 8:2 agent:premix; (b) fixing said coating on said substrate; and (c) drying said coated substrate such that the coated substrate, when dry, protects against air- or solution-borne pathogens and, when wet, releases the anti-pathogenic agent to substantially immediately eliminate the pathogens.

Claim 15

Dependent Claim 110 words

A process for producing a substrate coated with a formulation containing an anti-pathogenic component comprising: (a) depositing onto at least one surface of a substrate material a coating formulation in solution, characterized by the inclusion of PVP-I and N-9 as the active anti-pathogenic agent in a ratio of from about 100:0 to about 0:100 respectively and further including a premix solution in a ratio of about 6:4 to about 8:2 agent:premix; (b) fixing said coating on said substrate; and (c) drying said coated substrate such that the coated substrate, when dry, protects against air- or solution-borne pathogens and, when wet, releases the anti-pathogenic agent to substantially immediately eliminate the pathogens.

Claim 16

Dependent Claim 114 words

A coated substrate comprising a substrate material in intimate contact with an anti-pathogenic agent-containing solution characterized by the ability to release an anti-pathogenic agent immediately upon contact with a solution-borne pathogen to eliminate substantially immediately the pathogenic activity of the pathogen, wherein the anti-pathogenic agent-containing solution comprises (a) from about 30% by weight to about 80% by weight of an anti-pathogenic agent comprising a solution containing PVP-I and N-9; and (b) from about 20% by weight to about 70% by weight of a premix solution and wherein the anti-pathogenic agent-containing solution exhibits a percent solids of between about 10% and about 50% and a viscosity of between about 50 cps and about 600 cps.

Claim 17

Dependent Claim 114 words

A coated substrate comprising a substrate material in intimate contact with an anti-pathogenic agent-containing solution characterized by the ability to release an anti-pathogenic agent immediately upon contact with a solution-borne pathogen to eliminate substantially immediately the pathogenic activity of the pathogen, wherein the anti-pathogenic agent-containing solution comprises (a) from about 30% by weight to about 80% by weight of an anti-pathogenic agent comprising a solution containing PVP-I and N-9; and (b) from about 20% by weight to about 70% by weight of a premix solution and wherein the anti-pathogenic agent-containing solution exhibits a percent solids of between about 10% and about 50% and a viscosity of between about 50 cps and about 600 cps.

Claim 18

Dependent Claim 24 words

The coated substrate as in claim 14 wherein the premix solution contains a hydrophilic polymeric binder, a nonionic suffactant, an excipient, and a solvent.

Claim 19

Dependent Claim 23 words

The coated substrate as in claim 14 wherein the premix solution contains polyethylene glycol, hydroxypropyl methylcellulose, polyoxyethylene sorbitan, hydrous magnesium silicate, and ethanol.

Claim 20

Dependent Claim 32 words

The coated substrate as in claim 14 wherein the coating solution exhibits a percent solids of from about 25% to about 35% and a viscosity of between 90 cps and 130 cps.

Claim 21

Dependent Claim 35 words

The coated substrate as in claim 14 wherein the coating solution exhibits a percent solids of about 30% to about 32% and the substrate is a paper substrate coated by the reverse roll coating method.

Claim 22

Dependent Claim 40 words

The coated substrate as in claim 14 wherein the coating solution exhibits a percent solids of about 20% and the substrate is selected form the group consisting of non-woven laminates and paper/film laminates coated by the reverse roll coating method.

Claim 23

Dependent Claim 34 words

The coated substrate as in claim 14 wherein the coating solution exhibits a percent solids of about 30% to about 33% and the substrate is a non-woven laminate coated by a rod coating method.

Claim 24

Dependent Claim 22 words

The coated substrate as in claim 14 wherein the coating composition further includes a component to enhance water resistance of the substrate.

Claim 25

Dependent Claim 16 words

The coated substrate as in claim 14 wherein the coating solution further includes a coloring component.

Claim 26

Dependent Claim 162 words

An anti-pathogenic solution comprising a solution characterized by a % solids of 31.4% and the inclusion of a solution of PVP-I and N-9 as the active anti-pathogenic agent, the components of the solution being present in a ratio of from about 100:0 to about 0:100 PVP-I:N-9 and further including premix solution, wherein on a wet weight basis the anti-pathogenic agent solution comprises 71.5% by weight active anti-pathogenic agent and 28.5% by weight premix solution, and further wherein the active anti-pathogenic agent comprises 93.3% by weight PVP-I and 6.7% by weight N-9 and the premix solution comprises 54.6% by weight polyethylene glycol solution in distilled water and ethanol, 5.4% by weight polyoxyethylene sorbitan monoolete, 11.5% by weight talc, and 21.3% by weight ethanol solvent or the equivalent dry weight for each component consistent with the recited % solids, the anti-pathogenic solution exhibiting a viscosity between about 90 cps and about 130 cps, the solution substantially completely eliminating pathogens from a surface upon contact.

Claim 27

Dependent Claim 162 words

An anti-pathogenic solution comprising a solution characterized by a % solids of 31.4% and the inclusion of a solution of PVP-I and N-9 as the active anti-pathogenic agent, the components of the solution being present in a ratio of from about 100:0 to about 0:100 PVP-I:N-9 and further including premix solution, wherein on a wet weight basis the anti-pathogenic agent solution comprises 71.5% by weight active anti-pathogenic agent and 28.5% by weight premix solution, and further wherein the active anti-pathogenic agent comprises 93.3% by weight PVP-I and 6.7% by weight N-9 and the premix solution comprises 54.6% by weight polyethylene glycol solution in distilled water and ethanol, 5.4% by weight polyoxyethylene sorbitan monoolete, 11.5% by weight talc, and 21.3% by weight ethanol solvent or the equivalent dry weight for each component consistent with the recited % solids, the anti-pathogenic solution exhibiting a viscosity between about 90 cps and about 130 cps, the solution substantially completely eliminating pathogens from a surface upon contact.

Claim 28

Dependent Claim 169 words

A process for preparing an anti-pathogenic coating composition for coating paper, plastic, woven and non-woven substrates and combinations thereof, comprising: (a) preparing a solution of polyethylene glycol (PEG) in a mixture of alcohol and water; (b) adding a suffactant comprising a polyethylene glycol sorbitan fatty acid ester compound and an alcohol/water solution to the PEG solution with stirring until homogeneously mixed; (c) adding to the mixture of step (b) a pre-prepared powder mixture comprising hydroxypropyl methylcellulose and hydrous magnesium silicate and stirring to obtain a homogenous solution of the powder mixture of step (b); (d) stirring the solution of step (c) for a time sufficient to affect a homogenous mixture thereof; and (e) adding with stirring to the homogenous solution of step (d) a pre-prepared solution comprising a mixture of (1) a solution of PVP-I in an ethanol/water solvent and (2) a solution of N-9 in an ethanol/water solvent, the resulting anti-pathogenic composition having percent solids of about 25% to about 35% and a viscosity of about 50-600 cps.

Claim 29

Dependent Claim 169 words

A process for preparing an anti-pathogenic coating composition for coating paper, plastic, woven and non-woven substrates and combinations thereof, comprising: (a) preparing a solution of polyethylene glycol (PEG) in a mixture of alcohol and water; (b) adding a suffactant comprising a polyethylene glycol sorbitan fatty acid ester compound and an alcohol/water solution to the PEG solution with stirring until homogeneously mixed; (c) adding to the mixture of step (b) a pre-prepared powder mixture comprising hydroxypropyl methylcellulose and hydrous magnesium silicate and stirring to obtain a homogenous solution of the powder mixture of step (b); (d) stirring the solution of step (c) for a time sufficient to affect a homogenous mixture thereof; and (e) adding with stirring to the homogenous solution of step (d) a pre-prepared solution comprising a mixture of (1) a solution of PVP-I in an ethanol/water solvent and (2) a solution of N-9 in an ethanol/water solvent, the resulting anti-pathogenic composition having percent solids of about 25% to about 35% and a viscosity of about 50-600 cps.

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	2000-10-06	2001-04-07	2001-10-07	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2004-10-06	2005-04-07	2005-10-07	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2008-10-06	2009-04-07	2009-10-07	$7700.00	Window Closed / Lapsed

Anti-bacterial/anti-viral coatings, coating process and parameters thereof

Abstract

Inventors

Bibliographic Details

Claims Analysis

References Cited (Backward Citations)

USPTO Annuity & Maintenance Windows

Assigned Categories & Tags

Assign Category Tag